Cargando…

Interleukin-31 and Pruritic Skin

Skin inflammation often evokes pruritus, which is the major subjective symptom in many inflammatory skin diseases such as atopic dermatitis and prurigo nodularis. Pruritus or itch is a specific sensation found only in the skin. Recent studies have stressed the pivotal role played by interleukin-31 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Furue, Masutaka, Furue, Mihoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124688/
https://www.ncbi.nlm.nih.gov/pubmed/33924978
http://dx.doi.org/10.3390/jcm10091906
_version_ 1783693280953761792
author Furue, Masutaka
Furue, Mihoko
author_facet Furue, Masutaka
Furue, Mihoko
author_sort Furue, Masutaka
collection PubMed
description Skin inflammation often evokes pruritus, which is the major subjective symptom in many inflammatory skin diseases such as atopic dermatitis and prurigo nodularis. Pruritus or itch is a specific sensation found only in the skin. Recent studies have stressed the pivotal role played by interleukin-31 (IL-31) in the sensation of pruritus. IL-31 is produced by various cells including T helper 2 cells, macrophages, dendritic cells and eosinophils. IL-31 signals via a heterodimeric receptor composed of IL-31 receptor A (IL-31RA) and oncostatin M receptor β. Recent clinical trials have shown that the anti-IL-31RA antibody nemolizumab can successfully decrease pruritus in patients with atopic dermatitis and prurigo nodularis. The IL-31 pathway and pruritic skin are highlighted in this review article.
format Online
Article
Text
id pubmed-8124688
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81246882021-05-17 Interleukin-31 and Pruritic Skin Furue, Masutaka Furue, Mihoko J Clin Med Review Skin inflammation often evokes pruritus, which is the major subjective symptom in many inflammatory skin diseases such as atopic dermatitis and prurigo nodularis. Pruritus or itch is a specific sensation found only in the skin. Recent studies have stressed the pivotal role played by interleukin-31 (IL-31) in the sensation of pruritus. IL-31 is produced by various cells including T helper 2 cells, macrophages, dendritic cells and eosinophils. IL-31 signals via a heterodimeric receptor composed of IL-31 receptor A (IL-31RA) and oncostatin M receptor β. Recent clinical trials have shown that the anti-IL-31RA antibody nemolizumab can successfully decrease pruritus in patients with atopic dermatitis and prurigo nodularis. The IL-31 pathway and pruritic skin are highlighted in this review article. MDPI 2021-04-28 /pmc/articles/PMC8124688/ /pubmed/33924978 http://dx.doi.org/10.3390/jcm10091906 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Furue, Masutaka
Furue, Mihoko
Interleukin-31 and Pruritic Skin
title Interleukin-31 and Pruritic Skin
title_full Interleukin-31 and Pruritic Skin
title_fullStr Interleukin-31 and Pruritic Skin
title_full_unstemmed Interleukin-31 and Pruritic Skin
title_short Interleukin-31 and Pruritic Skin
title_sort interleukin-31 and pruritic skin
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124688/
https://www.ncbi.nlm.nih.gov/pubmed/33924978
http://dx.doi.org/10.3390/jcm10091906
work_keys_str_mv AT furuemasutaka interleukin31andpruriticskin
AT furuemihoko interleukin31andpruriticskin